Related Experiment Video
Updated: Jul 19, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV
Massimiliano Lanzafame1, Emanuela Lattuada2, Dora Luise3
1Unit of Infectious Diseases, Department of Medical Area, "Santa Chiara" Hospital, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
Abstract:
The use of long-acting antiretroviral regimens will not be suitable for all people living with HIV for various reasons (previous virological failure with drugs of the same class, side effects, logistic difficulties, and costs). We think that short-cycle therapies could represent a feasible and valuable option for antiretroviral treatment optimization in selected individuals. So here we review clinical evidence about efficacy of short-cycle therapy in suppressed HIV-infected patients.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Sexually Transmitted Infections
Size and Structure of Viral Genomes
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

